Back to search

Article

Cross-Reactivity of SARS-CoV Structural Protein Antibodies Against SARS-CoV-2

2020-10-12

Abstract excerpt

In the ongoing COVID-19 pandemic, there remain essential unanswered questions regarding the nature and significance of the humoral immune response towards other coronavirus infections. In this study, we investigate the cross-reactivity of antibodies raised against the first SARS-CoV for their reactivity towards the novel SARS-CoV-2. We extensively characterize a selection of 10 antibodies covering all of the SARS-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8378561e-7bc6-5718-8384-5f25465e5d6d
DOI
10.2139/ssrn.3696769
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cross-Reactivity of SARS-CoV Structural Protein Antibodies Against SARS-CoV-2DOI 10.2139/ssrn.3696769
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2Semantic proximity
Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecovirusesSemantic proximity
Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecovirusesSemantic proximity
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with an endemic human CoVSemantic proximity
Cross neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spikeSemantic proximity
Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individualsSemantic proximity
Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variantsSemantic proximity
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronavirusesSemantic proximity
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studySemantic proximity
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodiesSemantic proximity
Peptide microarray‐based analysis of antibody responses to SARS‐CoV‐2 identifies unique epitopes with potential for diagnostic test developmentSemantic proximity
SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunitySemantic proximity
Select a neighboring publication to make it the new centre.